NCT00003023View on ClinicalTrials.gov

Monoclonal Antibody A1G4 Plus BCG in Treating Patients With Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

March 31, 1997

Primary Completion Date

January 31, 2005

Conditions
NeuroblastomaSarcoma
Interventions
BIOLOGICAL

BCG vaccine

BIOLOGICAL

monoclonal antibody A1G4 anti-idiotype vaccine

Trial Locations (1)

10021

Memorial Sloan-Kettering Cancer Center, New York

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

Memorial Sloan Kettering Cancer Center

OTHER